Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:13:25 EDT Fri 03 May 2024
Enter Symbol
or Name
USA
CA



News for U:RLMD from 2023-05-04 to 2024-05-03 - 18 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-19 16:15U:RLMDNews ReleaseRelmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-03-12 07:30U:RLMDNews ReleaseRelmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024
2024-03-05 07:30U:RLMDNews ReleaseRelmada Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
2024-01-04 07:30U:RLMDNews ReleaseRelmada Therapeutics Provides Corporate Update
2023-11-08 16:01U:RLMDNews ReleaseRelmada Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
2023-11-03 07:30U:RLMDNews ReleaseRelmada Therapeutics to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 8, 2023
2023-10-11 08:31U:RLMDNews ReleaseRelmada Therapeutics to Present New Preclinical Data on its Psilocybin Program at AASLD The Liver Meeting ‚ ® 2023
2023-10-09 07:30U:RLMDNews ReleaseRelmada Therapeutics to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
2023-10-06 07:30U:RLMDNews ReleaseRelmada Therapeutics to Present Data from its REL-1017 and Psilocybin Programs at the 36th European College of Neuropsychopharmacology (ECNP) Congress
2023-09-20 08:30U:RLMDNews ReleaseRelmada Therapeutics Announces Efficacy and Safety Results from the Phase 3 Long-Term Study of REL-1017 in Major Depressive Disorder
2023-08-23 07:30U:RLMDNews ReleaseRelmada Therapeutics Announces Dosing of First Patient in Relight, a Phase 3 Trial of REL-1017 for the Adjunctive Treatment of Major Depressive Disorder
2023-08-08 16:01U:RLMDNews ReleaseRelmada Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
2023-08-01 07:30U:RLMDNews ReleaseRelmada Therapeutics to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on August 8, 2023
2023-06-08 07:30U:RLMDNews ReleaseRelmada Therapeutics to Participate in the Goldman Sachs Global Healthcare Conference
2023-06-02 07:30U:RLMDNews ReleaseRelmada Therapeutics to Participate in the 2023 Jefferies Global Healthcare Conference
2023-05-24 07:30U:RLMDNews ReleaseRelmada Therapeutics to Present Data at the American Society of Clinical Psychopharmacology 2023 Annual Meeting
2023-05-11 16:04U:RLMDNews ReleaseRelmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
2023-05-08 07:30U:RLMDNews ReleaseRelmada Therapeutics to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 11, 2023